Option chain shows key data for Vivos's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Vivos.

Vivos (OTC:RDGL) Stock, Option Chain

Vivos Inc is a radiation oncology medical device company. It is engaged in the development of RadioGel which is a brachytherapy device comprising highly insoluble particles delivered by needle injection using a water-polymer composite for high-dose treatment of non-resectable solid tumors. IsoPet is another product of the company used for the treatment of solid tumors in animals. The company derives revenue through sales of its products.

Penny,Stock,Investments,Taking,Off,Concept

Long Ideas

News

Penny Stocks

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

PAPL

RDGL

VANI

Pineapple Financial And 1 Other Stock Under $1 Insiders Are Buying

Screenshot 2024-07-01 at 8.57.06 AM

Biotech

General

Vivos One Step Closer To Transforming Cancer Treatment With FDA Application To Start Human Trials For Pioneering Injectable Brachytherapy Device

Alset And 2 Other Stocks Under $2 Insiders Are Buying

Vivos Inc

<p>In the last three months, 15 analysts have published ratings on Ollie's Bargain Outlet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLLI#NASDAQ">OLLI</a>), offering a diverse range of perspectives from bullish to bearish.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">7</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">5</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $120.87, with a high estimate of $135.00 and a low estimate of $95.00. Marking an increase of 13.95%, the current average surpasses the previous average price target of $106.07. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734962452_0.png" alt="price target chart" /></p>
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
<p>The standing of Ollie's Bargain Outlet among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$130.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Anthony Chukumba</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$130.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Steven Zaccone</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$133.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Edward Kelly</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$105.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Anthony Chukumba</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$120.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Matthew Boss</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$135.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Jeremy Hamblin</td>
<td>Craig-Hallum</td>
<td>Raises</td>
<td>Buy</td>
<td>$130.00</td>
<td>$107.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$130.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Scot Ciccarelli</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$121.00</td>
<td>$109.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$130.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Peter Keith</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Overweight</td>
<td>$126.00</td>
<td>$107.00</td>
</tr>
<tr>
<td>Edward Kelly</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$95.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Peter Keith</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$107.00</td>
<td>$107.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$106.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Jason Haas</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$115.00</td>
<td>$102.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Ollie's Bargain Outlet. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Ollie's Bargain Outlet compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of Ollie's Bargain Outlet's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>For valuable insights into Ollie's Bargain Outlet's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/OLLI/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Ollie's Bargain Outlet analyst ratings.</strong></a></p>
<h2>Delving into Ollie's Bargain Outlet's Background</h2>
<p>Ollie's Bargain Outlet Holdings Inc is a retailer of brand-name merchandise at drastically reduced prices. It offers customers a selection of brand-name products, including housewares, food, books and stationery, bed and bath, floor coverings, toys, and hardware. It operates stores across the Eastern half of the United States. Its differentiated go-to-market plan is characterized by a fun, and engaging treasure hunt shopping experience, compelling customer value proposition, and witty, humorous in-store signage and advertising campaigns. These attributes have driven rapid growth and consistent store performance for the company.</p>
<h3>Ollie's Bargain Outlet's Economic Impact: An Analysis</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Revenue Growth:</strong> Ollie's Bargain Outlet's remarkable performance in 3 months is evident. As of 31 October, 2024, the company achieved an impressive revenue growth rate of <strong>7.79%</strong>. This signifies a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>6.94%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Ollie's Bargain Outlet's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>2.24%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> Ollie's Bargain Outlet's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive <strong>1.48%</strong> ROA, the company effectively utilizes its assets for optimal returns.</p>
<p><strong>Debt Management:</strong> Ollie's Bargain Outlet's debt-to-equity ratio is below the industry average at <strong>0.34</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.</p>
<p>Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Analyst Ratings

OLLI

Expert Outlook: Ollie's Bargain Outlet Through The Eyes Of 15 Analysts

<p>Throughout the last three months, 20 analysts have evaluated Datadog (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>), offering a diverse set of opinions from bullish to bearish.</p>
<p>Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">11</td>
<td align="right">9</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">6</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>In the assessment of 12-month price targets, analysts unveil insights for Datadog, presenting an average target of $159.8, a high estimate of $200.00, and a low estimate of $133.00. This upward trend is evident, with the current average reflecting a 10.21% increase from the previous average price target of $145.00.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734962444_0.png" alt="price target chart" /></p>
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
<p>The perception of Datadog by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Yun Kim</td>
<td>Loop Capital</td>
<td>Raises</td>
<td>Buy</td>
<td>$200.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Brad Reback</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$165.00</td>
<td>$141.00</td>
</tr>
<tr>
<td>Gregg Moskowitz</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$170.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Joel Fishbein</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$170.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Steve Koenig</td>
<td>Macquarie</td>
<td>Announces</td>
<td>Outperform</td>
<td>$200.00</td>
<td>-</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$187.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Andrew Sherman</td>
<td>TD Cowen</td>
<td>Maintains</td>
<td>Buy</td>
<td>$165.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$148.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$155.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Fatima Boolani</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$157.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Andrew Sherman</td>
<td>TD Cowen</td>
<td>Raises</td>
<td>Buy</td>
<td>$165.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$150.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Patrick Colville</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Outperform</td>
<td>$133.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>William Power</td>
<td>Baird</td>
<td>Raises</td>
<td>Outperform</td>
<td>$150.00</td>
<td>$140.00</td>
</tr>
<tr>
<td>Brian White</td>
<td>Monness, Crespi, Hardt</td>
<td>Announces</td>
<td>Buy</td>
<td>$155.00</td>
<td>-</td>
</tr>
<tr>
<td>Keith Bachman</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$135.00</td>
<td>$132.00</td>
</tr>
<tr>
<td>Peter Weed</td>
<td>Bernstein</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$151.00</td>
<td>$157.00</td>
</tr>
<tr>
<td>Karl Keirstead</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$150.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Andrew DeGasperi</td>
<td>Exane BNP Paribas</td>
<td>Announces</td>
<td>Outperform</td>
<td>$150.00</td>
<td>-</td>
</tr>
<tr>
<td>Gil Luria</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$140.00</td>
<td>$115.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Datadog. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Datadog compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of Datadog's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Datadog's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/DDOG/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Datadog analyst ratings.</strong></a></p>
<h2>Unveiling the Story Behind Datadog</h2>
<p>Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered via software as a service, allows a client to monitor and analyze its entire IT infrastructure. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of applications throughout their businesses.</p>
<h3>A Deep Dive into Datadog's Financials</h3>
<p><strong>Market Capitalization:</strong> With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.</p>
<p><strong>Positive Revenue Trend:</strong> Examining Datadog's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of <strong>26.02%</strong> as of 30 September, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.</p>
<p><strong>Net Margin:</strong> The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of <strong>7.49%,</strong> the company showcases strong profitability and effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> Datadog's ROE lags behind industry averages, suggesting challenges in maximizing returns on equity capital. With an ROE of <strong>2.05%,</strong> the company may face hurdles in achieving optimal financial performance.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>1.14%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Datadog's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.37</strong>.</p>
<h2>How Are Analyst Ratings Determined?</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


DDOG

What Analysts Are Saying About Datadog Stock

<p>12 analysts have shared their evaluations of BKV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BKV#NYSE">BKV</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.</p>
<p>The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">4</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">2</td>
<td align="right">5</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Insights from analysts' 12-month price targets are revealed, presenting an average target of $26.08, a high estimate of $33.00, and a low estimate of $23.00. This current average has increased by 4.32% from the previous average price target of $25.00. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734962434_0.png" alt="price target chart" /></p>
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
<p>The standing of BKV among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Tim Rezvan</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$25.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$33.00</td>
<td>$29.00</td>
</tr>
<tr>
<td>Bertrand Donnes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$25.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Raises</td>
<td>Positive</td>
<td>$25.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Bertrand Donnes</td>
<td>Truist Securities</td>
<td>Announces</td>
<td>Buy</td>
<td>$24.00</td>
<td>-</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Announces</td>
<td>Positive</td>
<td>$24.00</td>
<td>-</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Announces</td>
<td>Buy</td>
<td>$29.00</td>
<td>-</td>
</tr>
<tr>
<td>Stephen Richardson</td>
<td>Evercore ISI Group</td>
<td>Announces</td>
<td>Outperform</td>
<td>$24.00</td>
<td>-</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Announces</td>
<td>Overweight</td>
<td>$24.00</td>
<td>-</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Outperform</td>
<td>$29.00</td>
<td>-</td>
</tr>
<tr>
<td>Lloyd Byrne</td>
<td>Jefferies</td>
<td>Announces</td>
<td>Buy</td>
<td>$28.00</td>
<td>-</td>
</tr>
<tr>
<td>Tim Rezvan</td>
<td>Keybanc</td>
<td>Announces</td>
<td>Overweight</td>
<td>$23.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to BKV. This offers insight into analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of BKV compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts provide insights into price targets, offering estimates for the future value of BKV's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Capture valuable insights into BKV's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/BKV/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on BKV analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Delving into BKV's Background</h2>
<p>BKV Corp is a growth-driven energy company. Its core business is to produce natural gas from its owned and operated upstream businesses. It operates in four business lines: natural gas production, natural gas gathering, processing and transportation (natural gas midstream business), power generation and carbon capture, utilization, and sequestration (CCUS).</p>
<h3>BKV's Financial Performance</h3>
<p><strong>Market Capitalization Analysis:</strong> Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.</p>
<p><strong>Negative Revenue Trend:</strong> Examining BKV's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately <strong>-24.33%</strong> in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Energy sector, the company faces challenges, achieving a growth rate lower than the average among peers.</p>
<p><strong>Net Margin:</strong> BKV's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of <strong>9.34%,</strong> the company may encounter challenges in effective cost control.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of <strong>0.88%,</strong> the company may need to address challenges in generating satisfactory returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of <strong>0.57%,</strong> the company may need to address challenges in generating satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> BKV's debt-to-equity ratio is below the industry average at <strong>0.12</strong>, reflecting a lower dependency on debt financing and a more conservative financial approach.</p>
<h2>What Are Analyst Ratings?</h2>
<p>Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. </p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Forecasting The Future: 12 Analyst Projections For BKV

<p>13 analysts have shared their evaluations of Huntington Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBAN#NASDAQ">HBAN</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">3</td>
<td align="right">6</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $18.38, with a high estimate of $21.00 and a low estimate of $15.00. Surpassing the previous average price target of $16.98, the current average has increased by 8.24%.</p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734962426_0.png" alt="price target chart" /></p>
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
<p>The perception of Huntington Bancshares by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jon Arfstrom</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Jon Arfstrom</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>David Konrad</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$19.00</td>
<td>$16.00</td>
</tr>
<tr>
<td>Andrew Dietrich</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$20.00</td>
<td>$18.50</td>
</tr>
<tr>
<td>Scott Siefers</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Underweight</td>
<td>$17.50</td>
<td>$15.00</td>
</tr>
<tr>
<td>Ryan Nash</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$20.00</td>
<td>$16.25</td>
</tr>
<tr>
<td>Keith Horowitz</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$21.00</td>
<td>$18.00</td>
</tr>
<tr>
<td>John Pancari</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$18.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>Peter Winter</td>
<td>DA Davidson</td>
<td>Raises</td>
<td>Buy</td>
<td>$17.50</td>
<td>$16.50</td>
</tr>
<tr>
<td>Jason Goldberg</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$17.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Scott Siefers</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Underweight</td>
<td>$15.00</td>
<td>$14.00</td>
</tr>
<tr>
<td>Jon Arfstrom</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$17.00</td>
<td>$17.00</td>
</tr>
<tr>
<td>John Pancari</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$17.00</td>
<td>$17.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Huntington Bancshares. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li><strong>Rating:</strong> Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Huntington Bancshares compared to the broader market.</li>
<li><strong>Price Targets:</strong> Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
<p>Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Huntington Bancshares's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/HBAN/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on Huntington Bancshares analyst ratings.</strong></a></p>
<h2>Get to Know Huntington Bancshares Better</h2>
<p>Huntington is a regional us bank with around $200 billion in assets (as of September 2024) and has a large presence, particularly in the Midwestern market. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.</p>
<h3>Huntington Bancshares: Delving into Financials</h3>
<p><strong>Market Capitalization:</strong> Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.</p>
<p><strong>Negative Revenue Trend:</strong> Examining Huntington Bancshares's financials over 3 months reveals challenges. As of 30 September, 2024, the company experienced a decline of approximately <strong>-0.16%</strong> in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Financials sector.</p>
<p><strong>Net Margin:</strong> Huntington Bancshares's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of <strong>25.67%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>2.72%,</strong> the company showcases effective utilization of equity capital.</p>
<p><strong>Return on Assets (ROA):</strong> Huntington Bancshares's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of <strong>0.24%,</strong> the company may encounter challenges in delivering satisfactory returns from its assets.</p>
<p><strong>Debt Management:</strong> Huntington Bancshares's debt-to-equity ratio stands notably higher than the industry average, reaching <strong>0.9</strong>. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.</p>
<p>Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.</p>
<p><strong>Breaking: Wall Street's Next Big Mover</strong></p>
<p>Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights"><strong>Click here for urgent details</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


HBAN

Demystifying Huntington Bancshares: Insights From 13 Analyst Reviews

<p><a href="https://www.consumerfinance.gov/about-us/newsroom/cfpb-sues-walmart-and-branch-messenger-for-illegally-opening-deposit-accounts-for-more-than-one-million-delivery-drivers/#:~:text=WASHINTON%2C%20D.C.%20%E2%80%93%20Today%2C%20the,they%20could%20access%20their%20earnings" title="https://www.consumerfinance.gov/about-us/newsroom/cfpb-sues-walmart-and-branch-messenger-for-illegally-opening-deposit-accounts-for-more-than-one-million-delivery-drivers/#:~:text=WASHINTON%2C%20D.C.%20%E2%80%93%20Today%2C%20the,they%20could%20access%20their%20earnings">https://www.consumerfinance.gov/about-us/newsroom/cfpb-sues-walmart-and-branch-messenger-for-illegally-opening-deposit-accounts-for-more-than-one-million-delivery-drivers/#:~:text=WASHINTON%2C%20D.C.%20%E2%80%93%20Today%2C%20the,they%20could%20access%20their%20earnings</a>.</p>


CFPB Sues Walmart And Branch Messenger For Forcing Spark Drivers Into Costly Deposit Accounts Without Consent; Drivers Paid Over $10M In Fees To Access Earnings, Facing Delays And Misleading Payment Practices

<p><strong><u>Crypto</u></strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42644568/institutional-crypto-adoption-for-real-this-time-says-messari">Institutional Crypto Adoption &#8216;For Real This Time,&#8217; Says Messari</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42645811/dogecoin-shiba-inu-could-underperform-stronger-cryptos-trader-warns-heres-why">Dogecoin, Shiba Inu Could Underperform Stronger Cryptos, Trader Warns: Here&#8217;s Why</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42640482/dogecoin-turns-green-as-trump-appoints-loyalist-katie-miller-to-the-department-of-government-efficiency">Dogecoin Turns Green As Trump Appoints Loyalist Katie Miller To The Department Of Government Efficiency</a></li>
<li><a href="https://www.benzinga.com/24/12/42640293/trump-congratulates-bitcoiners-on-new-all-time-highs-as-apex-crypto-suffers-first-weekly-loss-since-election-triumph">Trump Congratulates Bitcoin Community On New All-Time Highs Just As Top Crypto Suffers First Weekly Loss Since His Election Triumph</a></li>
<li><a href="https://www.benzinga.com/24/12/42640011/peter-schiffs-sarcastic-remark-births-million-dollar-usacoin-meant-to-be-an-bitcoin-alternative">Peter Schiff&#8217;s &#8216;Sarcastic&#8217; Post Spurs Birth Of Supposed Bitcoin Alternative USAcoin With Millions In Marketcap, Economist Warns &#8216;Don&#8217;t Buy It&#8217;</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/12/42639832/bitcoin-ethereum-dogecoin-lose-sheen-ahead-of-holidays-but-top-analyst-points-to-this-indicator-says-btc-will-hit-a-top-above-168k">Bitcoin, Ethereum, Dogecoin Lose Sheen Ahead Of Holidays But Top Analyst Points To This Indicator, Says BTC Will Hit A Top Above $168K</a></li>
</ul>
<p><strong><u>US Markets­­­­­­­­</u></strong></p>
<ul>
<li><a href="https://www.benzinga.com/24/12/42644814/why-rumble-shares-are-trading-higher-by-around-43-here-are-20-stocks-moving-premarket">Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket</a></li>
<li><a href="https://www.benzinga.com/news/earnings/24/12/42643303/us-stocks-to-open-higher-as-wall-street-expects-santa-rally-in-shortened-trading-week-microstrategy-palantir-qualcomm-among-stocks-in-focus">US Stocks To Open Higher As Wall Street Expects &#8216;Santa Rally&#8217; In Shortened Trading Week: MicroStrategy, Palantir, Qualcomm Among Stocks In Focus</a></li>
<li><a href="https://www.benzinga.com/24/12/42642834/market-breadth-turns-positive-after-a-rare-14-day-negative-streak-history-suggests-gains-ahead">Market Breadth Rebounds As Risk Appetite Makes A Comeback: This Analyst Predicts Gains Ahead After S&amp;P 500&#8217;s Record Negative Streak</a></li>
<li><a href="https://www.benzinga.com/markets/24/12/42642021/dow-jumps-around-500-points-but-records-3rd-straight-weekly-loss-greed-index-moves-to-fear-zone">Dow Jumps Around 500 Points But Records 3rd Straight Weekly Loss: Greed Index Moves To &#8216;Fear&#8217; Zone</a></li>
</ul>
<p><strong><u>US Politics</u></strong></p>
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42642808/americas-fatal-flaw-is-its-sharply-increasing-addiction-to-government-debt-says-expert-and-the-mother-of-all-bubbles-is-ready-to-pop">America&#8217;s &#8216;Fatal Flaw&#8217; Is Its &#8216;Sharply Increasing Addiction&#8217; To Government Debt, Says Expert And The &#8216;Mother Of All Bubbles&#8217; Is Ready To Pop</a></li>
<li><a href="https://www.benzinga.com/news/24/12/42645558/jared-kushner-distances-himself-from-father-in-laws-political-influence-in-the-event-that-trump-was-elected-they-should-not-expect-anything-from-me">Jared Kushner Distances Himself From Father In Law&#8217;s Political Influence: &#8216;In The Event That Trump Was Elected&#8230;They Should Not Expect Anything From Me&#8217;</a></li>
<li><a href="https://www.benzinga.com/news/24/12/42640044/trump-fires-back-at-critics-and-denies-ceding-presidency-to-elon-musk-and-im-safe-he-wasnt-born-in-this-country">Trump Fires Back At Critics, Denies Ceding Presidency To Elon Musk: &#8216;I&#8217;m Safe &#8230; He Wasn&#8217;t Born In This Country&#8217;</a></li>
<li><a href="https://www.benzinga.com/24/12/42639812/trump-taps-sriram-krishnan-as-senior-ai-advisor-to-work-closely-with-ai-and-crypto-czar-david-sacks">Trump Taps Sriram Krishnan As Senior AI Advisor — Elon Musk Agrees New David Sacks Underling &#8216;Right Man For The Topic And The Time</a></li>
</ul>
<p><strong><u>World Politics</u></strong></p>
<ul>
<li><a href="https://www.benzinga.com/24/12/42644888/biden-administration-targets-chinese-firm-over-taiwan-semiconductor-chip-found-in-huawei-tech">Biden Administration Targets Chinese Firm Over Taiwan Semiconductor Chip Found in Huawei Tech</a></li>
<li><a href="https://www.benzinga.com/news/global/24/12/42643821/biden-administration-initiates-trade-probe-on-chinese-legacy-chips">Biden Administration Initiates Trade Probe On Chinese &#8216;Legacy&#8217; Chips</a></li>
<li><a href="https://www.benzinga.com/24/12/42640560/japan-cannot-happen-here-was-common-refrain-20-years-ago-in-the-west-mohammed-el-erian-says-as-tokyo-climbs-out-of-the-hole-this-country-looks-at-risk-of-falling-in">Mohammed El Erian Says This Country Faces Japan-Style Economic Risk Even As Tokyo Rebounds</a></li>
<li><a href="https://www.benzinga.com/24/12/42639737/trumps-call-to-reclaim-panama-canal-sparks-backlash-every-square-meter-belongs-to-panama-says-president-mulino">Trump&#8217;s Call To Reclaim Panama Canal Sparks Backlash: &#8216;Every Square Meter Belongs To Panama,&#8217; Says President Mulino</a></li>
</ul>
<p><strong><u>World Economy</u></strong></p>
<ul>
<li><a href="https://www.benzinga.com/24/12/42643291/dollar-rises-on-feds-rate-cut-projections-asia-markets-sees-broad-gains-led-by-japan-and-australia-europe-edges-lower-global-markets-today-while-us-slept">Dollar&#8217;s Strength Continues, Asia Ex-China Up, Europe Edges Lower &#8211; Global Markets Today While US Slept</a></li>
</ul>
<p><strong><u>Tech</u></strong></p>
<ul>
<li><a href="https://www.benzinga.com/tech/24/12/42642791/this-ai-artist-generates-5m-through-digital-art-auctions">This AI Artist Generates $5M Through Digital Art Auctions</a></li>
<li><a href="https://www.benzinga.com/24/12/42641018/google-faced-intense-scrutiny-post-chatgpt-leading-up-to-declaring-code-red-but-gemini-20-and-quantum-chip-gives-investors-renewed-confidence">Google Entered &#8216;Code Red&#8217; After ChatGPT Release, But Gemini 2.0 And Quantum Chip Give Investors &#8216;Renewed Confidence,&#8217; Says This Portfolio Manager</a></li>
<li><a href="https://www.benzinga.com/media/24/12/42640232/apple-airpods-to-get-heart-rate-temperature-sensors-and-cameras-to-help-with-ai-features-top-analyst">Apple AirPods To Get Heart Rate, Temperature Sensors, And Cameras To Help With AI Features: Top Analyst</a></li>
</ul>
<p><strong><u>Electric Vehicle</u></strong></p>
<ul>
<li><a href="https://www.benzinga.com/24/12/42642606/elon-musk-wants-to-raise-a-tesla-fleet-expert-estimates-vehicle-owners-can-make-40kyear-but-remains-doubtful">Tesla Analyst Estimates Vehicle Owners Can Make $40,000 A Year By Renting EVs To Robotaxi Fleet That Elon Musk Likened To A Combination Of Airbnb And Uber, But Will It Take Off?</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42642575/dan-ives-vs-gary-black-diverging-views-on-teslas-future-with-wedbush-analyst-bullish-on-robotaxis-and-optimus-while-the-future-fund-remains-cautious-on-earnings-growth">TSLA Stock Valuation Duel: Dan Ives Bets Big On Robotaxis While Gary Black Plays It Safe</a></li>
<li><a href="https://www.benzinga.com/24/12/42641207/researcher-says-cancelation-of-7500-ev-tax-credit-could-impact-teslas-deliveries-despite-ceo-elon-musk-claiming-otherwise">Tesla Deliveries At Risk If $7,500 EV Tax Credit Ends, Researcher Warns Despite CEO Elon Musk Claiming Otherwise</a></li>
<li><a href="https://www.benzinga.com/tech/24/12/42640472/tesla-exec-bemoans-cost-of-sending-letter-to-owners-affected-by-ev-giants-recent-recall-of-nearly-700000-vehicles">Tesla Exec Bemoans Cost Of Sending Letter To Owners Affected By EV Giant&#8217;s Recent Recall Of Nearly 700,000 Vehicles</a></li>
</ul>
<p><strong><u>Consumer</u></strong></p>
<ul>
<li><a href="https://www.benzinga.com/24/12/42642773/honda-nissan-start-merger-talks">Japanese Automakers Honda, Nissan Start Merger Talks: Mitsubishi Motors Considers Joining</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42640897/starbucks-strike-expands-to-more-us-cities-as-wage-negotiations-stall-during-busy-holiday-season">Starbucks Strike Expands To More US Cities As Wage Negotiations Stall During Busy Holiday Season</a></li>
</ul>
<p><strong><u>Communication</u></strong></p>
<ul>
<li><a href="https://www.benzinga.com/24/12/42645821/elon-musks-xai-expands-with-new-chatbot-app">Elon Musk&#8217;s xAI To Expand With New Chatbot App</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42640352/daniel-ek-spotify-board-members-sell-over-1-billion-in-shares-as-stock-surges-144-in-2024">Daniel Ek, Spotify Board Members Sell Over $1 Billion In Shares As Stock Surges 144% In 2024</a></li>
</ul>
<p><strong><u>Industrial</u></strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42642371/smith-wessons-fate-hangs-in-the-balance-as-supreme-court-weighs-mexicos-gun-trafficking-lawsuit-swbi-stock-down-27-over-past-month-heres-whats-next">Smith &amp; Wesson&#8217;s Fate Hangs In The Balance As Supreme Court Weighs Mexico&#8217;s Gun Trafficking Lawsuit: SWBI Stock Down 27% Over Past Month, Here&#8217;s What&#8217;s Next</a></li>
</ul>
<p><strong><u>Healthcare</u></strong></p>
<ul>
<li><a href="https://www.benzinga.com/24/12/42643620/exclusive-telomir-pharmaceuticals-unveils-breakthrough-potential-of-telomir-1-for-wilsons-disease-and-beyond">Telomir Pharmaceuticals Reports Potential Of Telomir-1 For Wilson&#8217;s Disease</a></li>
</ul>
<p><strong><u>Financial</u></strong></p>
<ul>
<li><a href="https://www.benzinga.com/tech/24/12/42641667/is-this-nancy-pelosis-stock-pick-set-to-overtake-nvidia-ai-chip-race-to-heat-up-by-2025-as-meta-and-microsoft-look-beyond-jensen-huangs-chip-maker-says-expert">Is This Nancy Pelosi&#8217;s Stock Pick Set To Overtake Nvidia? AI Chip Race To Heat Up By 2025 As Meta And Microsoft Look Beyond Jensen Huang&#8217;s Chip Maker, Says Expert</a></li>
</ul>
<p><strong><u>General</u></strong></p>
<ul>
<li><a href="https://www.benzinga.com/24/12/42640181/microstrategys-michael-saylor-proposes-digital-assets-framework-for-us-advocates-bitcoin-reserve-capable-of-generating-1681-trillion-in-wealth">Michael Saylor Proposes US Digital Assets Framework, Backs Bitcoin Reserve Capable Of Generating $16–$81 Trillion In Wealth</a></li>
</ul>
<p><strong><u>Space</u></strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42640010/palantir-and-anduril-reportedly-lead-consortium-partner-with-spacex-and-openai-to-compete-against-traditional-defense-contractors-in-850-billion-us-military-market">Palantir And Anduril Reportedly Lead Consortium, Partner With SpaceX And OpenAI To Compete Against Traditional Defense Contractors In $850 Billion US Military Market</a></li>
</ul>
<p><strong><u>Energy</u></strong></p>
<ul>
<li><a href="https://www.benzinga.com/markets/commodities/24/12/42645035/reviewing-benzingas-mining-watchlist-for-2024">Reviewing Benzinga&#8217;s Mining Watchlist For 2024</a></li>
</ul>
<p><em>Photo by SvetlanaParnikova on Shutterstock</em></p>


Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

Bitcoin, Ethereum, And Dogecoin Dip Pre-Holiday;  Biden Administration Targets Chinese Firm For Huawei Chip Linked To Taiwan Semiconductors; Honda And Nissan In Merger Talks - Top Headlines Today While US Slept

<p>Ratings for a.k.a. Brands Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AKA#NYSE">AKA</a>) were provided by 7 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.</p>
<p>The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.</p>
<table>
<thead>
<tr>
<th></th>
<th align="right"><strong>Bullish</strong></th>
<th align="right"><strong>Somewhat Bullish</strong></th>
<th align="right"><strong>Indifferent</strong></th>
<th align="right"><strong>Somewhat Bearish</strong></th>
<th align="right"><strong>Bearish</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Total Ratings</strong></td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>Last 30D</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>1M Ago</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>2M Ago</strong></td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td><strong>3M Ago</strong></td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
<p>Analysts have set 12-month price targets for a.k.a. Brands Holding, revealing an average target of $28.57, a high estimate of $30.00, and a low estimate of $25.00. Observing a 7.12% increase, the current average has risen from the previous average price target of $26.67. </p>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734962416_0.png" alt="price target chart" /></p>
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
<p>The analysis of recent analyst actions sheds light on the perception of a.k.a. Brands Holding by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.</p>
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$30.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$30.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Ryan Meyers</td>
<td>Lake Street</td>
<td>Announces</td>
<td>Buy</td>
<td>$30.00</td>
<td>-</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$30.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$25.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Raises</td>
<td>Buy</td>
<td>$30.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Eric Beder</td>
<td>Small Cap Consumer Research</td>
<td>Maintains</td>
<td>Buy</td>
<td>$25.00</td>
<td>$25.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li><strong>Action Taken:</strong> Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to a.k.a. Brands Holding. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li><strong>Rating:</strong> Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of a.k.a. Brands Holding compared to the broader market.</li>
<li><strong>Price Targets:</strong> Gaining insights, analysts provide estimates for the future value of a.k.a. Brands Holding's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
<p>Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into a.k.a. Brands Holding's market standing. Stay informed and make well-considered decisions with our Ratings Table.</p>
<p><a href="https://www.benzinga.com/quote/AKA/analyst-ratings?utm_source=Benzinga Insights"><strong>Stay up to date on a.k.a. Brands Holding analyst ratings.</strong></a></p>
<p>If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.</p>
<h2>Get to Know a.k.a. Brands Holding Better</h2>
<p>a.k.a. Brands Holding Corp is an online fashion retailer focused on acquiring and accelerating the growth of next-generation, digitally native fashion brands targeting Gen Z and Millennial customers. The brands of the company are two women's brands, Princess Polly and Petal &amp; Pup, and two streetwear brands, Culture Kings and mnml. The company derives maximum revenue from Australia/New Zealand.</p>
<h3>Breaking Down a.k.a. Brands Holding's Financial Performance</h3>
<p><strong>Market Capitalization Perspectives:</strong> The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.</p>
<p><strong>Revenue Growth:</strong> Over the 3 months period, a.k.a. Brands Holding showcased positive performance, achieving a revenue growth rate of <strong>6.44%</strong> as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Consumer Discretionary sector.</p>
<p><strong>Net Margin:</strong> a.k.a. Brands Holding's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of <strong>-3.63%,</strong> the company may face hurdles in effective cost management.</p>
<p><strong>Return on Equity (ROE):</strong> a.k.a. Brands Holding's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of <strong>-3.98%,</strong> the company may face hurdles in generating optimal returns for shareholders.</p>
<p><strong>Return on Assets (ROA):</strong> a.k.a. Brands Holding's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of <strong>-1.37%,</strong> the company may face hurdles in achieving optimal financial returns.</p>
<p><strong>Debt Management:</strong> a.k.a. Brands Holding's debt-to-equity ratio is below the industry average. With a ratio of <b>1.32</b>, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.</p>
<h2>The Basics of Analyst Ratings</h2>
<p>Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.</p>
<p>Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.</p>
<p>Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.</p>
<p><strong>Which Stocks Are Analysts Recommending Now?</strong></p>
<p>Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights"><strong>Click here to stay ahead of the market</strong></a>.</p>
<p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>


Where a.k.a. Brands Holding Stands With Analysts

<p>Regeneron Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) has outperformed the market over the past 15 years by 13.4% on an annualized basis producing an average annual return of 25.09%. Currently, Regeneron Pharmaceuticals has a market capitalization of $77.62 billion. </p>
<p><strong>Buying $100 In REGN:</strong> If an investor had bought $100 of REGN stock 15 years ago, it would be worth <strong>$2,876.43</strong> today based on a price of $706.33 for REGN at the time of writing.</p>
<h3>Regeneron Pharmaceuticals's Performance Over Last 15 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1734962415_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


REGN

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

SXTP

Sixty Degrees Pharmaceuticals And Tufts Medical Center Sign Patent License Agreement To Develop Tafenoquine For Babesiosis Treatment And Prevention; 60 Degrees Gains Exclusive Commercialization Rights With Revenue Sharing And Joint Patent Ownership For Future Use

<p>JP Morgan  analyst Jessica Fye   maintains Vertex Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) with a Overweight and lowers the price target from $503 to $500.</p>


Price Target

VRTX

JP Morgan Maintains Overweight on Vertex Pharmaceuticals, Lowers Price Target to $500

<p>RBC Capital  analyst Bora Lee   maintains Uniti Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNIT#NASDAQ">UNIT</a>) with a Sector Perform and raises the price target from $5.5 to $6.</p>


UNIT

RBC Capital Maintains Sector Perform on Uniti Group, Raises Price Target to $6

WIIM

Psyence Biomedical shares are trading lower after the company announced a $2M private placement.

<p>RBC Capital  analyst Jon Arfstrom   reiterates Huntington Bancshares (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HBAN#NASDAQ">HBAN</a>) with a Outperform and maintains $20 price target.</p>


Reiteration

RBC Capital Reiterates Outperform on Huntington Bancshares, Maintains $20 Price Target

<p><strong>CleanSpark Inc</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLSK#NASDAQ">CLSK</a>) shares are bouncing around Monday morning. The company announced it surpassed its year-end operating hashrate guidance and <a href="https://www.benzinga.com/pressreleases/24/12/n42644639/cleanspark-exceeds-2024-year-end-guidance-of-37-ehs-and-accelerates-2025-guidance">accelerated its outlook for 2025</a>. </p>
<p><strong>What Happened:</strong> CleanSpark said it has achieved and exceeded the previously announced year-end target of 37 EH/s and now has 37.5 EH/s of operating hashrate after its newest data centers in Tennessee and Wyoming were energized last week. The company expects to exceed 50 EH/s in the first half of 2025.</p>
<p>CleanSpark noted that fleet efficiency has reached 17.7 J/Th and is expected to improve as the company continues its strategic growth plans. </p>
<p>CleanSpark expects to achieve its growth targets through a mix of greenfield infrastructure development, organic growth via existing site expansion and strategic M&amp;A. All growth is expected to be funded with a portion of the proceeds of the company&#8217;s <a href="https://www.benzinga.com/trading-ideas/movers/24/12/42558246/cleanspark-is-outpacing-bitcoin-mining-peers-wednesday-whats-going-on">most recent offering</a>.&nbsp;</p>
<p><strong>See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42644568/institutional-crypto-adoption-for-real-this-time-says-messari">Institutional Crypto Adoption &#8216;For Real This Time,&#8217; Says Messari</a></strong></p>
<p>&#8220;Our teams have been hard at work throughout the entirety of this past year. We have delivered on our ambitious targets and expanded our hashrate nearly&nbsp;300%&nbsp;since the beginning of 2024. Achieving 37.5 EH/s with a fleet efficiency of 17.7 J/Th is a significant milestone, and we intend to continue adding highly efficient hashrate through the end of the year and into 2025,&#8221; said <strong>Zach Bradford</strong>, CEO and president of CleanSpark.</p>
<p>&#8220;Our growth and efficiency have resulted in a&nbsp;bitcoin&nbsp;treasury balance quickly approaching 10,000&nbsp;bitcoin, all of which we have mined. As we look to 2025, we intend to remain focused on&nbsp;bitcoin&nbsp;and mining efficiently utilizing operational excellence at scale.&#8221;</p>
<p>CleanSpark shares initially traded higher when the company announced the operating update. The stock began moving lower as <strong>Bitcoin</strong> (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) traded lower early Monday. Bitcoin was down about 2.12% over a 24-hour period, trading around $94,950 at the time of publication.</p>
<p><strong>CLSK Price Action:</strong> <a href="http://benzinga.com/quote/clsk">CleanSpark shares</a> were down 1.26% at $11.00 at the time of publication Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.</p>
<p><em>Photo: Shutterstock.</em></p>


Guidance

Movers

CLSK

What's Going On With CleanSpark Stock Monday?

<p>During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.</p>
<p>Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.</p>
<p>Below are the ratings of the most accurate analysts for three high-yielding stocks in the real estate sector.</p>
<h3 class="wp-block-heading"><strong>Omega Healthcare Investors, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OHI#NYSE">OHI</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield:</strong> 7.08%</li>
<li><strong>Wells Fargo </strong>analyst Connor Siversky assumed an Overweight rating and raised the price target from $40 to $43 on Oct. 1. This analyst has an accuracy rate of 65%.</li>
<li><strong>Truist Securities</strong> analyst Michael Lewis maintained a Hold rating and raised the price target from $33 to $39 on Sept. 4. This analyst has an accuracy rate of 71%.</li>
<li><strong>Recent News:</strong> On Oct. 30, Omega Healthcare Investors reported better-than-expected third-quarter financial results and raised its FY24 adjusted FFO guidance.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122324&amp;t=be2bearmibe3na1">latest OHI news</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122324&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="910" height="840" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23085216/image-188.png" alt="" class="wp-image-704244" style="width:688px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23085216/image-188.png 910w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23085216/image-188-300x277.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23085216/image-188-768x709.png 768w" sizes="(max-width: 910px) 100vw, 910px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>OUTFRONT Media Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUT#NYSE">OUT</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield:</strong> 6.60%</li>
<li><strong>Morgan Stanley </strong>analyst Benjamin Swinburne maintained an Equal-Weight rating and raised the price target from $17 to $18 on Dec. 18. This analyst has an accuracy rate of 76%.</li>
<li><strong>Barrington Research </strong>analyst James Goss maintained an Outperform rating with a price target of $21 on Nov. 13. This analyst has an accuracy rate of 62%.</li>
<li><strong>Recent News: </strong>On Nov. 12, Outfront Media posted mixed quarterly results.</li>
<li>Benzinga Pro's real-time newsfeed alerted to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122324&amp;t=be2bearmibe3na1">latest OUT news</a> </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122324&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="892" height="833" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23085251/image-189.png" alt="" class="wp-image-704245" style="width:575px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23085251/image-189.png 892w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23085251/image-189-300x280.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23085251/image-189-768x717.png 768w" sizes="(max-width: 892px) 100vw, 892px" /></a></figure></p>
<h3 class="wp-block-heading"><strong>LTC Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LTC#NYSE">LTC</a>)</strong></h3>
<ul>
<li><strong>Dividend Yield: </strong>6.50%</li>
<li><strong>Wells Fargo </strong>analyst Connor Siversky assumed an Equal-Weight rating and raised the price target from $36 to $37 on Oct. 1. This analyst has an accuracy rate of 65%.</li>
<li><strong>Wedbush </strong>analyst Richard Anderson reiterated an Outperform rating and a price target of $40 on Sept. 20. This analyst has an accuracy rate of 65%.</li>
<li><strong>Recent News: </strong>LTC named Wendy Simpson Executive Chairman Of The Board, promoted Pam Kessler and Clint Malin to co-Chief Executive Officers, and Cece Chikhale Tto Chief Financial Officer, effective Dec. 31.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122324&amp;t=be2bearmibe3na1"> trend in LTC stock</a>. </li>
</ul>
<p><figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent122324&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="898" height="837" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23085334/image-190.png" alt="" class="wp-image-704248" style="width:623px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23085334/image-190.png 898w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23085334/image-190-300x280.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/23085334/image-190-768x716.png 768w" sizes="(max-width: 898px) 100vw, 898px" /></a></figure></p>
<p><figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"><br />
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
<p></p></figure></p>
<p><strong>Read More: </strong></p>
<ul>
<li><strong><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/12/42616196/jim-cramer-likes-walmart-recommends-buying-this-very-very-good-financial-stock">Jim Cramer Likes Walmart, Recommends Buying This &#8216;Very, Very Good&#8217; Financial Stock</a></strong></li>
</ul>


Dividends

Wall Street's Most Accurate Analysts Spotlight On 3 Real Estate Stocks Delivering High-Dividend Yields

XBIT

Trading Halt: Halted at 8:55:10 a.m. ET - Trading Halt: Halt News Pending

<p><strong>Faraday Future Intelligent Electric Inc. </strong>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) shares are trading higher premarket on Monday. On Sunday, the company disclosed securing around <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42639115/faraday-future-secures-30-million-financing-to-strengthen-the-companys-core-business-and-continued" rel="noreferrer noopener">$30 million in cash financing commitments</a>.</p>
<p>The financing comprises $7.5 million pre-funded in the fourth quarter of 2024 and $22.5 million in new cash commitments structured as unsecured convertible notes and warrants.</p>
<p>The Convertible Notes have a conversion price of $1.16 per share, while the Warrants are exercisable at $1.392 per share, subject to adjustments.</p>
<p>The underlying shares are currently unregistered and not immediately tradable. The financing remains subject to customary closing conditions.</p>
<p>The funds will support the development of Faraday X (FX). The company is targeting the mainstream U.S. EV market with plans to deliver its first two FX prototype mules to Los Angeles later this month.</p>
<p>Product development and testing will commence at the company's Hanford, CA, manufacturing facility.</p>
<p>FFIE CEO Matthias Aydt said, "The new funding lays a solid foundation for both FF and its new brand as the Company approaches the end of 2024 and enters the new year."</p>
<p>"I am optimistic about the opportunities that this new funding will bring, including supporting the ongoing production of our FF 91 2.0 and the growth of the FX brand."</p>
<p>Last month, the company announced the launch of a development phase after its first FX <a target="_blank" href="https://www.benzinga.com/news/global/24/11/42092678/whats-going-on-with-faraday-future-intelligent-electric-stock" rel="noreferrer noopener">prototypes&nbsp;arrived at its headquarters</a>.</p>
<p><strong>Price Action</strong>: FFIE shares are up 12.07% at $1.3000 premarket at the last check Monday.</p>
<p><strong>Read Next</strong>:</p>
<ul>
<li><strong><a href="https://www.benzinga.com/markets/equities/24/10/41541997/revving-up-in-the-middle-east-faradays-new-uae-headquarters-solidifies-ev-expansion-strategy" target="_blank" rel="noreferrer noopener">Revving Up In The Middle East: Faraday's New UAE Headquarters Solidifies EV Expansion Strategy</a></strong></li>
</ul>
<p><em>Photo Courtesy of Faraday Future Intelligent Electric</em></p>


Equities

Financing

Small Cap

FFIE

Why Is Faraday Future Intelligent Electric Trading Higher On Monday?

IKNA

Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times

AILE

iLearningEngines shares are trading lower after the company announced it voluntarily filed for Chapter 11 Bankruptcy,

<p>RBC Capital  analyst Gregory Renza   reiterates Jasper Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JSPR#NASDAQ">JSPR</a>) with a Outperform and maintains $68 price target.</p>


Jasper Therapeutics, Inc. - Class A Common Stock

JSPR

RBC Capital Reiterates Outperform on Jasper Therapeutics, Maintains $68 Price Target

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>I cannot stress enough how risky OTC stocks or securities traded over the counter really are. For one thing, just the name OTC should ring some alarm bells. This designation means that these securities don&rsquo;t trade on exchanges like the <strong>New York Stock Exchange</strong> or the <strong>Nasdaq</strong>. Instead, they trade via broker-dealer networks. And not all stock platforms support what&rsquo;s otherwise known as the pink sheets.</p>



<p>Second, many investors are shocked to discover the administrative costs tied to OTC stocks. Yes, many of these securities are &ldquo;cheap,&rdquo; trading hands at unit prices well below a buck. However, that doesn&rsquo;t mean that it&rsquo;s cheap to <em>you</em>. Wide bid-ask spreads may mean that your holdings may have to rise significantly higher to be net profitable. Also, even if you are profitable, low trading volume could mean a long time to find a buyer.</p>



<p>At the same time, OTC stocks or otherwise highly speculative shares can fly higher. Some <a href="https://www.gobankingrates.com/investing/stocks/most-successful-penny-stocks-ever/">examples</a> include the following:</p>



<ul><li><strong>Monster Beverage</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/mnst-stock-quote/"><strong>MNST</strong></a>): In 1997, you could have had MNST for just two cents.</li>



<li><strong>Apple</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/aapl-stock-quote/"><strong>AAPL</strong></a>): On a split-adjusted basis, you could have bought AAPL for 10 cents in December 1980.</li>



<li><strong>Advanced Micro Devices</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/amd-stock-quote/"><strong>AMD</strong></a>): Back in June 2015, AMD traded for below $2.</li>
</ul><p>Of course, there are way more failures than successes. But if you want to go for gold, below are the OTC stocks to consider.</p>



<h2>Tencent (TCEHY)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/08/tcehy-stock-3-300x169.jpg" alt="Tencent (TCEHY) sign on Tencent headquarters in Shenzhen, China."><div>Source: StreetVJ / Shutterstock.com</div></div>


<p>A Chinese multinational technology conglomerate, <strong>Tencent</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/tcehy-stock-quote/"><strong>TCEHY</strong></a>) has had a rough outing in 2023. Mainly, that&rsquo;s due to the challenging circumstances surrounding the Chinese economy. And if a <em>CNN</em> report proves correct, 2024 <a href="https://www.cnn.com/2023/12/27/economy/china-economy-challenges-2024-intl-hnk/index.html">could be an even rougher outing</a>. Still, Tencent&rsquo;s <a href="https://www.reuters.com/technology/tencent-reveals-most-ambitious-game-yet-consoles-amid-global-expansion-2023-12-08/">expansionary ambitions</a> reach beyond its home nation. With eyes on Japan, South Korea, Southeast Asia, and <a href="https://www.prnewswire.com/apac/news-releases/tencent-cloud-highlights-collaborative-global-expansion-with-digital-ecological-partners-at-tencent-cloud-digital-ecosystem-summit-2023-global-connect-session-301921841.html#:~:text=Fred%20Sun%2C%20General%20Manager%20of,East%2C%20providing%20solutions%20for%20various">several other international regions</a>, Tencent could be interesting for speculators.</p>



<p>To be sure, with a market capitalization of around $337.5 billion, TCEHY doesn&rsquo;t exactly rate as one of the typical OTC stocks. However, it&rsquo;s a great confidence booster because it&rsquo;s in some ways the best of both worlds: offering tremendous upside potential while also being a technology stalwart in its home nation.</p>



<p>Analysts rate shares a <a href="https://www.tipranks.com/stocks/tcehy">consensus moderate buy</a> with a $49.56 average price target. That implies an upside potential of over 40%. What&rsquo;s more, the high-side target hits $61.13, possibly delivering growth of over 73%. If that wasn&rsquo;t enough to whet your appetite, shares <a href="https://www.gurufocus.com/stock/TCEHY/summary?search=tcehy">trade at only 13.06X forward earnings</a>, below the interactive media sector&rsquo;s median value of 21.19X.</p>



<h2>BYD (BYDDF)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/09/byddf-stock-1-300x169.jpg" alt="A close-up view of the power supply plugged into a vehicle from BYD Company (BYDDY)."><div>Source: J. Lekavicius / Shutterstock.com</div></div>


<p>Moving on to another Chinese company, <strong>BYD</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/byddf-stock-quote/"><strong>BYDDF</strong></a>) presents a unique proposition. First, it&rsquo;s a major automotive enterprise specializing in electric vehicles, yet it technically ranks among the OTC stocks. Second, Warren Buffett &ndash; who is best known for investing in reliable blue chips &ndash; <a href="https://www.cnbc.com/berkshire-hathaway-portfolio/">owns BYD</a> via <strong>Berkshire Hathaway</strong> (NYSE:<span><a href="https://investorplace.com/stock-quotes/brk-b-stock-quote/"><strong>BRK-B</strong></a></span>). To be fair, Buffett has been <a href="https://apnews.com/article/berkshire-hathaway-warren-buffett-byd-397410cefd128f283c5efcc7cf90c1fa">reducing his exposure</a> but he still owns a sizable amount.</p>



<p>Despite the seemingly contradictory tone, investors may want to consider adding BYDDF to their portfolio. Yeah, it&rsquo;s one of the OTC stocks and yes, the Chinese economy looks rather putrid if I&rsquo;m being honest. However, with EVs becoming increasingly commoditized, guess who&rsquo;s going to win that battle? There&rsquo;s just no way that western nations can compete with their higher labor costs.</p>



<p>Also, investors should consider another element: demand. European politicians may want to reduce the flood of Chinese EVs. But their constituents? They love &lsquo;em. So do analysts, who rate BYDDF a <a href="https://www.tipranks.com/stocks/byddf/forecast">consensus strong buy</a> with a $36.03 price target. That implies 63% upside potential.</p>



<h2>Xiaomi (XIACF)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/05/electric-vehicle-charger1600-300x169.png" alt="Power supply connect to electric vehicle for charge to the battery. Charging technology industry transport which are the futuristic of the Automobile. EV fuel Plug in hybrid car."><div>Source: buffaloboy / Shutterstock.com</div></div>


<p>Yet one more Chinese company to discuss and then we&rsquo;ll get into the really wild OTC stocks. A designer and manufacturer of consumer electronics and related software, <strong>Xiaomi</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/xiacf-stock-quote/"><strong>XIACF</strong></a>) is a cynical play. For example, beyond its consumer electronics business, it&rsquo;s also involved in the EV space. Recently, the company <a href="https://www.cnbc.com/2023/12/28/chinas-xiaomi-unveils-first-ev-in-bid-to-compete-with-porsche-tesla.html">launched its first electric-powered vehicle</a>, which might have caught the eyes of some lawyers.</p>



<p>I&rsquo;m joking there, but seriously, the <a href="https://www.mi.com/global/discover/article?id=3095&amp;ref=upstract.com">Xiaomi SU7</a> looks like it ripped off the design of a particular German brand. But if the consumers who love BYD offer any clues, the SU7 should be a hit. Apparently, it has the performance (<a href="https://www.topspeed.com/xiaomi-su7-ev-facts/#:~:text=Performance%20Specifications&amp;text=The%20SU7%20Max%20trim%20will,top%20speed%20of%20165%20mph.">up to 664 horsepower</a>) and the longevity to <a href="https://www.carscoops.com/2023/12/xiaomis-su7-will-outrun-a-taycan-and-outlast-a-tesla-model-s/">better the top players in the ecosystem</a>. And even if you didn&rsquo;t like the EV pivot, Xiaomi should win in consumer electronics.</p>



<p>Frankly, with smart devices becoming so commoditized, people may start looking to price more often than brand. If so, XIACF has a clear pathway to robust shareholder profits. Analysts agree, rating the stock a <a href="https://www.tipranks.com/stocks/xiacf/forecast">unanimous strong buy</a> with a $2.66 average price target.</p>



<h2>Quisitive Technology Solutions (QUISF)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/cloud1600d-300x169.jpg" alt=""><div>Source: Shutterstock</div></div>


<p>Okay, let&rsquo;s buckle up for some serious OTC stocks and by that, I mean high risk, high reward. First, <strong>Quisitive Technology Solutions</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/quisf-stock-quote/"><strong>QUISF</strong></a>) bills itself as a premier global <strong>Microsoft</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/msft-stock-quote/"><strong>MSFT</strong></a>) partner that harnesses its cloud platforms and complete technologies to generate transformational impact for midsize and enterprise-level customers. It&rsquo;s an intriguing idea because, at one point, shares closed at $1.54 on a weekly average basis.</p>



<p>Currently, QUISF trades hands at only 22 cents. And you should note that over the past 52 weeks, it lost more than 53% of its equity value. Further, according to the security&rsquo;s point-and-figure (P&amp;F) chart, it prints a double bottom breakdown. According to StockCharts.com&rsquo;s educational section, this pattern is a bearish signal. That said, the pattern should also be viewed in a <a href="https://school.stockcharts.com/doku.php?id=chart_analysis:pnf_charts:pnf_bearish_bd#:~:text=for%20price%20objectives.-,Double%20Bottom%20Breakdown,These%20patterns%20are%20not%20contradictory.">broader context</a> due to possible whipsaw effects.</p>



<p>And what is that context? Basically, the broader cloud computing market <a href="https://www.fortunebusinessinsights.com/cloud-computing-market-102697">could be worth $2.43 trillion</a> by 2030. Quisitive just needs to take a bite out of this market to potentially drive higher. Analysts seem to be on the same page, pegging the <a href="https://www.tipranks.com/stocks/quisf/forecast">average price target at 49 cents</a>.</p>



<h2>Peninsula Energy (PENMF)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/uranium1600-300x169.jpg" alt="periodic table concept with black cubes. uranium element is glowing. Uranium stocks"><div>Source: Shutterstock</div></div>


<p>As a fan of the uranium energy space, I perked up when I came across this opportunity hidden among OTC stocks. As a uranium extraction specialist, <strong>Peninsula Energy</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/penmf-stock-quote/"><strong>PENMF</strong></a>) addresses a critical supply shortage that recently sprouted. According to <em>The Wall Street Journal</em>, last month, <a href="https://www.wsj.com/finance/commodities-futures/uranium-prices-jump-to-16-year-high-on-supply-woes-analysis-05c7086f">uranium prices jumped to a 16-year high</a> after one of the world&rsquo;s largest producers &ndash; Kazakhstan&rsquo;s state-owned company <strong>Kazatomprom</strong> &ndash; warned of production target shortfalls.</p>



<p>With uranium supplies uncertain for the next two years, several uranium players have skyrocketed. One of the exceptions is PENMF. In the trailing one-year period, the security declined by 8%. That said, it is up 15% on a year-to-date basis but that&rsquo;s a modest performance compared to exchange-listed uranium specialists.</p>



<p>Still, as far as OTC stocks are concerned, Peninsula could be intriguing because of geopolitical considerations. Basically, it features 100% ownership of the Lance Project, which is one of the largest uranium projects in the U.S.</p>



<p>Better yet, analysts expect great things, pegging shares a moderate buy with a 17-cent target. That implies almost 85% upside potential, with the high-side target landing at 22 cents.</p>



<h2>Saturn Oil &amp; Gas (OILSF)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/03/oilandgasstocks1600-300x169.png" alt="Panorama of Oil and Gas central processing platform in twilight, offshore hard work occupation twenty four working hours. Best oil stocks to buy"><div>Source: Oil and Gas Photographer / Shutterstock.com</div></div>


<p>Based in Calgary, Alberta, Canada, <strong>Saturn Oil &amp; Gas</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/oilsf-stock-quote/"><strong>OILSF</strong></a>) is a resource company engaged in the business of acquisition, exploration and development of petroleum and natural gas resource despoits in Western Canada. Further, the company&rsquo;s current focus is to advance the exploration and development of its oil and gas properties in Alberta and Saskatchewan.</p>



<p>As an upstream player in the hydrocarbon space, Saturn might not seem particularly relevant. Late last year, many oil-producing nations <a href="https://www.cnn.com/2023/11/30/energy/saudi-arabia-extend-production-cut-opec/index.html">agreed to cut production in a bid to bolster prices</a>. However, that effort did not succeed. Also, <em>Reuters</em> recently reported that rising U.S. oil production has <a href="https://www.reuters.com/markets/commodities/rising-us-oil-production-frustrates-opec-cuts-kemp-2024-02-01/">frustrated the aforementioned oil producers</a>. So, it seems OILSF could be one of the losing OTC stocks.</p>



<p>However, the blowout <a href="https://finance.yahoo.com/news/january-jobs-report-us-economy-adds-353000-jobs-blowing-past-wall-street-expectations-133251408.html">January jobs report</a> suggests that we shouldn&rsquo;t quite give up on black gold just yet. More people with jobs should translate to more resource consumption. And to be blunt, renewable energy just won&rsquo;t be enough to feed the growing demand profile. Notably, Echelon Wealth Partners believes OILSF <a href="https://www.tipranks.com/stocks/oilsf/forecast">could hit $4.22 per share or 137% up</a>.</p>



<h2>Vivos (RDGL)</h2>


<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/07/medical-bills-1600-300x169.png" alt="Doctor or physician calculating a patients medical bills at a desk. Medical bills, health costs, health expenses."><div>Source: THICHA SATAPITANON / Shutterstock</div></div>


<p>Before discussing radiation oncology medical device firm <strong>Vivos</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/rdgl-stock-quote/"><strong>RDGL</strong></a>), it&rsquo;s important to disclose that I own RDGL stock. Please make a decision based on your own due diligence and a sober reflection of your risk tolerance. This is a security that has already lost almost 28% YTD and is likely subject to severe market turbulence.</p>



<p>With the caveats out of the way, Vivos is engaged in the development of its <a href="https://www.radiogel.com">yttrium-90-based brachytherapy device, RadioGel</a>, for the treatment of non-resectable tumors. According to Johns Hopkins Medicine, brachytherapy is a <a href="https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/brachytherapy">radiation treatment</a> that is given directly into the patient&rsquo;s body. Typically, the radiation is deployed using tiny devices such as wires, seeds, or rods filled with radioactive materials.</p>



<p>Where Vivos distinguishes itself is that RadioGel utilizes an injectable particle-gel, which delivers a very high local radiation dose. More broadly, RDGL entices speculators because the underlying industry is still in its early innings, <a href="https://www.grandviewresearch.com/industry-analysis/brachytherapy-devices-market">worth $907.76 million in 2022</a>.</p>



<p>As for a price target, it&rsquo;s difficult to say as no analyst currently covers RDGL. However, <a href="https://upperdeckoptions.com/2024/01/31/rdgl-stock-a-potential-sentiment-shift-in-2023/">based on my personal research</a>, I believe around 5 cents is the bottom.</p>



<p><strong><a href="https://investorplace.com/stock-types/penny-stocks/">Penny Stocks</a></strong></p>



<p><strong><em>On Penny Stocks and Low-Volume Stocks:</em></strong><em>&nbsp;With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&nbsp;<a href="http://investorplace.com/">InvestorPlace.com</a>&rsquo;s writers disclose this fact and warn readers of the risks.</em></p>



<p><em>Read More:&nbsp;Penny Stocks &mdash;&nbsp;</em><a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/"><em>How to Profit Without Getting Scammed</em></a></p>



<p><em>On the date of publication, Josh Enomoto</em><em>&nbsp;held a LONG position in&nbsp;RDGL. </em><em>The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<div><p>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT766413">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/02/high-risk-high-reward-7-otc-stocks-that-could-make-you-rich-this-year/">High-Risk, High-Reward: 7 OTC Stocks That Could Make You Rich This Year</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

High-Risk, High-Reward: 7 OTC Stocks That Could Make You Rich This Year

<p><a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a></p>
<p>If you want millionaire-maker stocks, go consult Warren Buffett. The Oracle of Omaha has plenty of compelling ideas. However, if you want to reach millionaire status quickly, you&rsquo;re going to need to dial up the risk factor.</p>



<p>Here, the narrative is quite simple. If you want to give yourself a realistic possibility &ndash; note I didn&rsquo;t say probability &ndash; of winning big, you&rsquo;ve got to target extremely speculative market ideas. Usually, that means <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a> or shares that are priced so low they can benefit from the law of small numbers.</p>



<p>However, once the initial liftoff is achieved, the beneficiary enterprises need attractive businesses to keep the fire burning. Arguably, the below companies have exactly that &ndash; but you better be prepared for extreme volatility. On that note, take a look at these millionaire-maker stocks.</p>



<h2>Knightscope (KSCP)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/03/kscp-stock-300x169.png" alt="An image of a Knightscope, Inc. (KSCP) robot in a parking garage"><div>Source: Sundry Photography / Shutterstock.com</div></div><p>Billed as a security camera and robotics firm, <strong>Knightscope</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/kscp-stock-quote/"><strong>KSCP</strong></a>) designs, builds, and deploys robots called <a href="https://www.knightscope.com">Autonomous Data Robots</a>. This solution allows for the monitoring of people in malls, parking lots, neighborhoods, and other public areas. Fundamentally, the main positive catalyst for KSCP stock centers on security.</p>



<p>As a Californian, one news item caught my eye: the popular In-N-Out Burger will <a href="https://apnews.com/article/oakland-innout-burger-closing-crime-9cd8f43eb43fe781086b9e277eb0724d#:~:text=January%2026%2C%202024-,OAKLAND%2C%20Calif.,only%20restaurant%20in%20Oakland%2C%20California.">close its first location</a> in its 75-year history in Oakland. To the chagrin of residents, a wave of car break-ins, property damage, theft, and robberies affecting both customers and employees took their toll on the business. It&rsquo;s incidents like this multiplied at a scale that demonstrates the forward viability of KSCP as one of the millionaire-maker stocks.</p>



<p>To be sure, Knightscope carries significant risks, including <a href="https://www.gurufocus.com/stock/KSCP/analysis/warning-signs">several severe ones</a>, per investment data aggregator Gurufocus. Still, after a rough patch in getting the business moving, the company has printed encouraging <a href="https://www.gurufocus.com/stock/KSCP/financials">revenue growth</a> recently.</p>



<p><a href="https://www.businesswire.com/news/home/20240104703804/en/Ascendiant-Capital-Markets-Maintains-Buy-Rating-for-Knightscope-Raises-Per-Share-Price-Target-to-4.00">Ascendiant&rsquo;s Edward Woo believes shares can hit $4</a>. If so, we&rsquo;re talking upside potential of over 692%.</p>



<h2>Quantum Computing (QUBT)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/09/quantum-computing-3-300x169.jpg" alt="A concept image showing a quantum computer with a matrix background; quantum computing. leading quantum stocks, quantum computing stocks to buy"><div>Source: Shutterstock</div></div><p>I love companies that explain what they do just with their title. Here on this list of millionaire-maker stocks, we have <strong>Quantum Computing</strong> (NASDAQ:<a href="https://investorplace.com/stock-quotes/qubt-stock-quote/"><strong>QUBT</strong></a>). It doesn&rsquo;t get much more direct than that. In all seriousness, the company is pioneering the production of photonic hardware solutions using non-linear quantum optics. This innovation should allow exponential acceleration in computing, machine learning, cybersecurity and other advanced fields.</p>



<p>According to Fortune Business Insights, the market itself is relatively small, landing at only $928.8 million last year. However, it&rsquo;s expanding at a tremendous clip; a compound annual growth rate (CAGR) of 32.1% to 2030, per analysts&rsquo; projections. If that rate holds true, the quantum computing sector <a href="https://www.fortunebusinessinsights.com/quantum-computing-market-104855#:~:text=The%20quantum%20computing%20market%20size,share%20of%2042.97%25%20in%202022.">could be worth approximately $6.53 billion</a>.</p>



<p>For context, QUBT stock only printed a market capitalization of just under $59 million. So, if the stars align, Quantum could easily rank among the millionaire-maker stocks.</p>



<p>Sure enough, <a href="https://finance.yahoo.com/news/7-analyst-backed-stocks-promising-000957206.html">Ascendiant&rsquo;s Woo also endorses QUBT, targeting $8.75</a> or around 1,015% up from Wednesday&rsquo;s close.</p>



<h2>Vivos (RDGL)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/10/biomedical-technology1600-300x169.png" alt="Modern Medical Research Laboratory with Computer, Microscope, Glassware with Biochemicals on the Desk. Scientific Lab Biotechnology Development Center Full of High-Tech Equipment. Biomedical technology stocks, RSLS Stock"><div>Source: Gorodenkoff / Shutterstock.com</div></div><p>If you want to know what a dedicated fanbase for a publicly traded security looks like, <a href="https://twitter.com/EnomotoMedia">check out my X account</a>. Here, you&rsquo;re going to find plenty of discussions and expressions of adoration for medical technology firm <strong>Vivos</strong> (OTCMKTS:<a href="https://investorplace.com/stock-quotes/rdgl-stock-quote/"><strong>RDGL</strong></a>). Yes, it&rsquo;s traded over the counter. Yes, it&rsquo;s a six-cent stock. No, it&rsquo;s not something out of the movie &ldquo;The Wolf of Wall Street.&rdquo;</p>



<p>Instead, what we have here is a radiation oncology specialist. Focusing on an advanced form of brachytherapy, Vivos utilizes radioactive materials (yttrium-90) to directly implement a high-dose treatment to the target area while imposing a minimal dosage to surrounding healthy tissue. Brachytherapy is already a promising therapeutic approach, which should see a 7.1% CAGR <a href="https://www.grandviewresearch.com/industry-analysis/brachytherapy-devices-market">to land at a value of $1.62 billion by 2030</a>.</p>



<p>Here&rsquo;s what&rsquo;s really intriguing about Vivos: it improves upon brachytherapy through a minimally invasive procedure that leverages a hydrogel solution to deliver the cancer-fighting therapeutic. Following the implementation, the hydrogel is safely absorbed by the body. Vivos appears unique in its brachytherapy-based approach. Therefore, I have personally put my money where my mouth is here.</p>



<p><strong><em>On Penny Stocks and Low-Volume Stocks:&#8239;</em></strong><em>With only the rarest exceptions,&nbsp;InvestorPlace&nbsp;does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;penny stocks&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;InvestorPlace.com&rsquo;s&nbsp;writers disclose this fact and warn readers of the risks.</em></p>



<p><strong><em>Read More:&#8239;</em></strong><a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank"><em>Penny Stocks &mdash;&nbsp;How to Profit Without Getting Scammed</em></a></p>



<p><em>On the date of publication, Josh Enomoto</em><em>&nbsp;held a LONG position in RDGL. </em><em>The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;</em><a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank"><em>Publishing Guidelines</em></a><em>.</em></p>
<div><p>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</p></div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/07/venture-capitalist-predicts-this-chatgpt-announcement-will-shock-the-world/?cid=MKT744191&amp;eid=MKT766413">ChatGPT IPO Could Shock the World, Make This Move Before the Announcement</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
<p>The post <a href="https://investorplace.com/2024/02/3-stocks-to-turn-1000-into-1-million-february-2024/">3 Stocks to Turn $1,000 Into $1 Million: February 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.</p>

3 Stocks to Turn $1,000 Into $1 Million: February 2024

Vivos Inc (RDGL) has issued an update. Vivos, Inc. has renewed its Executive Employment Agreement with CEO Dr. Michael Korenko, effective January 1...

Vivos Inc Secures Leadership Continuity with CEO Contract Renewal

Catalyst Watch: Disney earnings, Apple iPad event and Fed speakers back on the circuit

AAPL

ABNB

AFRM

AMCX

ASCUF

AZTR

BYDDF

BYND

CABA

COST

CPNG

CPRI

CRSP

DCPH

EDIT

FGEN

KNSL

KOPN

KSCP

LAZR

MBLY

MCBC

MNST

MSFT

NDAQ

NISTF

NKLA

NRGV

OILSF

PENMF

PLTR

QUBT

QUISF

RACE

RBLX

RDDT

RIVN

SAVE

SHOP

SNAP

TCEHY

TSLA

UBER

UPST

USFD

VSTO

VZIO

XIACF

ZYXI

Press Releases

Vivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials

Vivos Inc. Provides IDE Submission Status Update – Conversion to Pre-Sub Filing Accepted by the FDA

Vivos Inc. Extended its IsoPet® Precision Radionuclide TherapyTM to Exotics

Vivos Inc. Certifies New Clinic for IsoPet® Precision Radionuclide TherapyTM

Vivos Inc. Announces Launch of Groundbreaking RadioGel® Precision Radionuclide Therapy™ Human Clinical Trial

Vivos

Comments

Vivos

Vivos (RDGL) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga